These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 32293456)

  • 41. Activation of paraoxonase 1 is associated with HDL remodeling ex vivo.
    Gugliucci A
    Clin Chim Acta; 2014 Feb; 429():38-45. PubMed ID: 24280342
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dietary modifications and gene polymorphisms alter serum paraoxonase activity in healthy women.
    Rantala M; Silaste ML; Tuominen A; Kaikkonen J; Salonen JT; Alfthan G; Aro A; Kesäniemi YA
    J Nutr; 2002 Oct; 132(10):3012-7. PubMed ID: 12368388
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Relationship between selected oxidative stress markers and lipid risk factors for cardiovascular disease in middle-aged adults and its possible clinical relevance.
    Viktorinova A; Svitekova K; Stecova A; Krizko M
    Clin Biochem; 2016 Aug; 49(12):868-72. PubMed ID: 27240017
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Di-oleoyl phosphatidylcholine (PC-18:1) stimulates paraoxonase 1 (PON1) enzymatic and biological activities: in vitro and in vivo studies.
    Efrat M; Rosenblat M; Mahmood S; Vaya J; Aviram M
    Atherosclerosis; 2009 Feb; 202(2):461-9. PubMed ID: 18585720
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Anti-oxidative and cholesterol efflux capacities of high-density lipoprotein are reduced in ischaemic cardiomyopathy.
    Patel PJ; Khera AV; Wilensky RL; Rader DJ
    Eur J Heart Fail; 2013 Nov; 15(11):1215-9. PubMed ID: 23709232
    [TBL] [Abstract][Full Text] [Related]  

  • 46. HDL3 stimulates paraoxonase 1 antiatherogenic catalytic and biological activities in a macrophage model system: in vivo and in vitro studies.
    Rosenblat M; Volkova N; Aviram M
    Biofactors; 2014; 40(5):536-45. PubMed ID: 25230879
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cholesterol efflux capacity, HDL cholesterol, and risk of coronary heart disease: a nested case-control study in men.
    Cahill LE; Sacks FM; Rimm EB; Jensen MK
    J Lipid Res; 2019 Aug; 60(8):1457-1464. PubMed ID: 31142574
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Association between paraoxonase 1 activity and severity of coronary artery disease in patients with acute coronary syndromes.
    Sentürk T; Sarandöl E; Güllülü S; Erdinç S; Ozdemir B; Baran I; Aydinlar A
    Acta Cardiol; 2008 Jun; 63(3):361-7. PubMed ID: 18664028
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Beneficial Effects of Exercise-Based Cardiac Rehabilitation on High-Density Lipoprotein-Mediated Cholesterol Efflux Capacity in Patients with Acute Coronary Syndrome.
    Koba S; Ayaori M; Uto-Kondo H; Furuyama F; Yokota Y; Tsunoda F; Shoji M; Ikewaki K; Kobayashi Y
    J Atheroscler Thromb; 2016 Jul; 23(7):865-77. PubMed ID: 26947596
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reduced paraoxonase1 activity is a risk for atherosclerosis in patients with systemic lupus erythematosus.
    Kiss E; Seres I; Tarr T; Kocsis Z; Szegedi G; Paragh G
    Ann N Y Acad Sci; 2007 Jun; 1108():83-91. PubMed ID: 17893973
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Association between serum paraoxonase activity and oxidative stress in acute coronary syndromes.
    Kabaroglu C; Mutaf I; Boydak B; Ozmen D; Habif S; Erdener D; Parildar Z; Bayindir O
    Acta Cardiol; 2004 Dec; 59(6):606-11. PubMed ID: 15636443
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Association Between Very Low Levels of High-Density Lipoprotein Cholesterol and Long-term Outcomes of Patients With Acute Coronary Syndrome Treated Without Revascularization: Insights From the TRILOGY ACS Trial.
    Hagström E; Roe MT; Hafley G; Neely ML; Sidhu MS; Winters KJ; Prabhakaran D; White HD; Armstrong PW; Fox KA; Ohman EM; Boden WE;
    Clin Cardiol; 2016 Jun; 39(6):329-37. PubMed ID: 27177240
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Association of serum amyloid A and oxidative stress with paraoxonase 1 in sarcoidosis patients.
    Ivanišević J; Kotur-Stevuljević J; Stefanović A; Spasić S; Vučinić Mihailović V; Videnović Ivanov J; Jelić-Ivanović Z
    Eur J Clin Invest; 2016 May; 46(5):418-24. PubMed ID: 26919159
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Is non-HDL-cholesterol a better predictor of long-term outcome in patients after acute myocardial infarction compared to LDL-cholesterol? : a retrospective study.
    Wongcharoen W; Sutthiwutthichai S; Gunaparn S; Phrommintikul A
    BMC Cardiovasc Disord; 2017 Jan; 17(1):10. PubMed ID: 28056802
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Functional and proteomic alterations of plasma high density lipoproteins in type 1 diabetes mellitus.
    Manjunatha S; Distelmaier K; Dasari S; Carter RE; Kudva YC; Nair KS
    Metabolism; 2016 Sep; 65(9):1421-31. PubMed ID: 27506748
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High-density lipoprotein composition and paraoxonase activity in Type I diabetes.
    Valabhji J; McColl AJ; Schachter M; Dhanjil S; Richmond W; Elkeles RS
    Clin Sci (Lond); 2001 Dec; 101(6):659-70. PubMed ID: 11724654
    [TBL] [Abstract][Full Text] [Related]  

  • 57. HDL cholesterol efflux capacity is related to disease activity in psoriatic arthritis patients.
    Ferraz-Amaro I; Hernández-Hernández MV; Armas-González E; Sánchez-Pérez H; Machado JD; Díaz-González F
    Clin Rheumatol; 2020 Jun; 39(6):1871-1880. PubMed ID: 31993889
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential.
    Ribas V; Sánchez-Quesada JL; Antón R; Camacho M; Julve J; Escolà-Gil JC; Vila L; Ordóñez-Llanos J; Blanco-Vaca F
    Circ Res; 2004 Oct; 95(8):789-97. PubMed ID: 15388641
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lower than average HDL cholesterol efflux capacity in Lithuanian population.
    Kutkiene S; Petrulioniene Z; Karciauskaite D; Laucevicius A; Matuzevicienė G; Staigyte J; Mikulskiene AS; Gargalskaite U; Skiauteryte E; Kovaite M
    Lipids Health Dis; 2019 Oct; 18(1):186. PubMed ID: 31655593
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Determinants of HDL Cholesterol Efflux Capacity after Virgin Olive Oil Ingestion: Interrelationships with Fluidity of HDL Monolayer.
    Fernández-Castillejo S; Rubió L; Hernáez Á; Catalán Ú; Pedret A; Valls RM; Mosele JI; Covas MI; Remaley AT; Castañer O; Motilva MJ; Solá R
    Mol Nutr Food Res; 2017 Dec; 61(12):. PubMed ID: 28887843
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.